Persist AI Teams up with Microsize and Micromacinazione (Micmac) to Launch First-of-Its-Kind Early-Stage "Micromill" Formulation Platform, Enabling Drug Development Decision With Milligrams of API

Summary

Persist AI has partnered with Microsize and Micromacinazione to launch a micromill formulation platform enabling drug development decisions using milligram quantities of active pharmaceutical ingredients. The integrated workflow combines solubility studies, dissolution testing, stability analysis, and in-process analytics at early-stage scale.